The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Vitamin Shoppe's revenues will expand 15.9% and EPS will grow 9.1%.
The average estimate for revenue is $284.0 million. On the bottom line, the average EPS estimate is $0.60.
Last quarter, Vitamin Shoppe logged revenue of $279.1 million. GAAP reported sales were 13% higher than the prior-year quarter's $248.1 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.
Last quarter, non-GAAP EPS came in at $0.72. GAAP EPS of $0.68 for Q1 were 11% higher than the prior-year quarter's $0.61 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures are normalized by S&P Capital IQ and may vary to maintain comparability with normalized estimates.
For the preceding quarter, gross margin was 36.4%, 80 basis points better than the prior-year quarter. Operating margin was 13.1%, 80 basis points better than the prior-year quarter. Net margin was 7.5%, 10 basis points better than the prior-year quarter.
The full year's average estimate for revenue is $1.10 billion. The average EPS estimate is $2.29.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 52 members out of 64 rating the stock outperform, and 12 members rating it underperform. Among 28 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 19 give Vitamin Shoppe a green thumbs-up, and nine give it a red thumbs-down.
Is Vitamin Shoppe the right retailer for your portfolio? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average retailing powerhouse. Click here for instant access to this free report.
- Add Vitamin Shoppe to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.